Researchers conducted a cohort study to assess the effect of incretin receptor agonist therapy on continuous positive airway pressure use in T2D, obesity, and OSA.
India's top drug maker Sun Pharmaceutical Industries has announced today the launch of a generic version of semaglutide, the ...
Mounjaro (tirzepatide) is a prescription drug for adults and certain children with type 2 diabetes. One of the more common side effects of Mounjaro is constipation. In clinical studies, constipation ...
Nutrition professionals are involved in few studies incorporating nutritional interventions or dietary assessments for patients receiving semaglutide or tirzepatide. HealthDay News — Nutritional ...
At 36 weeks, the TOGETHER-PsA study met its primary endpoint of 50% improvement in psoriatic arthritis (PsA) activity based on ACR50 in addition to ≥10% weight reduction with concomitant Taltz and ...
Systemic lupus erythematosus (SLE) is a prototypic systemic autoimmune disease characterised by loss of tolerance, widespread immune dysregulation, and production of diverse autoantibodies (typically ...
As evidence of tirzepatide’s efficacy mounts across a range of cardiometabolic conditions, Eli Lilly has shown that taking the incretin medicine alongside another of its drugs, Taltz, could lead to ...
Tirzepatide and semaglutide would have to drop their current net prices by 30.5% and 81.9%, respectively, to be cost-effective. Over a lifetime of use, tirzepatide could avert 45,609 obesity cases, 20 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results